Iheanacho undergoes medical ahead Leicester move
Connect with us

Sports

Iheanacho undergoes medical ahead Leicester move

Published

on

Iheanacho undergoes medical ahead Leicester move

Super Eagles striker, Kelechi Iheanacho, is very close to completing a move to former Premier League champions, Leicester City, as he underwent a medical on Tuesday.

This was revealed by Manchester City (@City_watch) on Twitter via a photo of the striker lying on a bed wearing Leicester jersey and being tested by a medical professional.

The photo had the caption: “Kelechi Iheanacho undergoing his Leicester City medical. Announcement should come soon.”

According to reports, Iheanacho will pen a four-year deal with Leicester with the option of a further year, with a buy- back clause (insisted on by Manchester City) included in his transfer.

Read Also: EPL: Man City are the team to beat – Giggs

Iheanacho, who scored 21 goals in 64 games in all competitions since making his debut for City in 2015, has been rarely given a start under manager Pep Guardiola.

The 20-year old finished last season as third-choice striker behind Sergio Aguero and Gabriel Jesus, netting seven times in 28 games in the Premier League.

Leicester reportedly made a £25 million offer for him, but the amount will be confirmed when the announcement of the move is made official.

Iheanacho would be joining his compatriots Wilfred Ndidi and Ahmed Musa at the King Power Stadium.

By Ben Ugbana

RipplesNigeria ….without borders, without fears

Click here to download the Ripples Nigeria App for latest updates

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now

Exit mobile version